Koen Keirse

A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial

William A. Gray, Koen Keirse, Yoshimitsu Soga et al. · The Lancet · 2018 · 279 citations

Zilver Ptx, Paclitaxel-eluting Stent, Endovascular Technique +8

Results of the Protégé EverFlex 200-mm-long nitinol stent (ev3) in TASC C and D femoropopliteal lesions

Marc Bosiers, Koen Deloose, Joren Callaert et al. · Journal of Vascular Surgery · 2011 · 147 citations · Full text

Tasc C, Vascular Surgery, Surgery +2

Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease

Stefan Müller‐Hülsbeck, Koen Keirse, Thomas Zeller et al. · Journal of Endovascular Therapy · 2016 · 97 citations · Full text

Long-Term Results from the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Femoropopliteal Treatment: 3-Year Follow-up

Stefan Müller‐Hülsbeck, Koen Keirse, Thomas Zeller et al. · CardioVascular and Interventional Radiology · 2017 · 85 citations

Eluvia Paclitaxel-eluting Stent, Endovascular Technique, Vascular Surgery +7

Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease

Marianne Brodmann, Koen Keirse, Dierk Scheinert et al. · JACC: Cardiovascular Interventions · 2017 · 69 citations · Full text